Since CGL2 patients have systemic multi-organ damage, we endeavour to characterise the phenotype of CGL2 patients from metabolic disorders and their complications, physical features, neurological symptoms, reproductive system symptoms, and others (Table 2). The gene discussed is GZMH; the disease is metabolic disease.